Oak Family Advisors’s Pfizer PFE Stock Holding History

Oak Family Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,016	Closed	-$211K	–	130
2022 Q2	$211K	Hold	4,016	–	–	0.11%	119
2022 Q1	$208K	Sell	4,016 -1,725	-30%	-$89.5K	0.08%	133
2021 Q4	$339K	Sell	5,741 -795	-12%	-$39.4K	0.13%	109
2021 Q3	$281K	Sell	6,536 -800	-11%	-$35.4K	0.1%	120
2021 Q2	$287K	Sell	7,336 -27,318	-79%	-$1.06M	0.12%	83
2021 Q1	$1.26M	Sell	34,654 -989	-3%	-$35.1K	0.55%	38
2020 Q4	$1.31M	Buy	+35,643	New	+$1.31M	0.68%	37

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Oak Family Advisors's PFE Position: Q3 2022 in Review

Oak Family Advisors sold out of Pfizer (PFE) in Q3 2022, closing a stake of 4,016 shares — an estimated $211K sold.

Oak Family Advisors first reported a position in PFE in Q4 2020 and held it in 7 quarters. The position peaked at $1.31M in Q4 2020. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.

Oak Family Advisors reported no remaining Pfizer position as of Q3 2022 after selling out during the quarter.
Oak Family Advisors sold 4,016 Pfizer shares in Q3 2022, an estimated $211K.
Oak Family Advisors first reported a position in Pfizer in Q4 2020 and held it in 7 quarters.
Oak Family Advisors's Pfizer position peaked at $1.31M in Q4 2020.
3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.

Based on Oak Family Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.